Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Deloitte
Fuji
Federal Trade Commission
Dow
Baxter
Harvard Business School
Queensland Health

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075279

« Back to Dashboard

NDA 075279 describes CLOBETASOL PROPIONATE, which is a drug marketed by Ingenus Pharms Llc, Perrigo Israel, Fougera Pharms Inc, G And W Labs Inc, Lupin Ltd, Mylan Pharms Inc, Taro, Teva Pharms Usa, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Actavis Mid Atlantic, Glenmark Pharms, Zydus Pharms Usa Inc, Hi-tech Pharmacal, Macleods Pharms Ltd, Novel Labs Inc, Tolmar, Wockhardt Bio Ag, Akorn, Paddock Llc, and Novast Labs Ltd, and is included in forty-five NDAs. It is available from thirty-two suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 075279
Tradename:CLOBETASOL PROPIONATE
Applicant:Taro
Ingredient:clobetasol propionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 075279
Medical Subject Heading (MeSH) Categories for 075279
Suppliers and Packaging for NDA: 075279
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 075279 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1294 N 51672-1294-1
CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 075279 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1294 N 51672-1294-2

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.05%
Approval Date:May 28, 1999TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Boehringer Ingelheim
Covington
Express Scripts
Medtronic
Queensland Health
Colorcon
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.